Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
3.370
+0.030 (0.90%)
At close: Mar 9, 2026, 4:00 PM EDT
3.321
-0.049 (-1.46%)
After-hours: Mar 9, 2026, 7:56 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Checkpoint
41.00K103.00K---
Checkpoint Growth
-60.19%----
Journey
56.13M79.18M---
Journey Growth
-29.11%----
Fortress
1.50M5.23M---
Fortress Growth
-71.31%----
Dermatology Products Sales
--73.67M63.13M44.53M
Dermatology Products Sales Growth
--16.69%41.78%27.52%
Pharmaceutical and Biotechnology Product Development
--2.07M5.66M1.07M
Pharmaceutical and Biotechnology Product Development Growth
---63.34%429.68%-37.47%
Total
57.68M84.51M75.74M68.79M45.60M
Total Growth
-31.76%11.58%10.11%50.86%24.49%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
United States of America
57.68M84.51M75.74M68.79M45.60M
United States of America Growth
-31.76%11.58%10.11%50.86%24.49%
Total
57.68M84.51M75.74M68.79M45.60M
Total Growth
-31.76%11.58%10.11%50.86%24.49%
Source: S&P Global Market Intelligence.